Browsing: Q&A
Life Risk News’ monthly Q&A articles with life risk industry insiders
The pension risk transfer market in the UK has delivered plenty of talking points in 2025 so far in what has been another busy year for the space. Greg Winterton spoke to Pretty Sagoo, Managing Director of Defined Benefit Solutions at Just Group, to get a risk buyer’s perspective on the current state of the market and the outlook for the balance of the year.
Carl Groth, Chief Risk Officer at Legal & General Retirement America, offers his thoughts on the state of the US pension risk transfer market as we enter H2.
Life Risk News Q&A: Perry Koons, Director of Capital Markets at life settlement provider Maple Life Financial, offers his thoughts on the state of the life settlement market at the halfway point of 2025.
Life Risk News Q&A: Matthew Sheridan of Health Data Analytics Institute to get his thoughts on how predictive modelling is helping US health systems to better triage patients and model risk.
Shelly Beard, Managing Director at WTW, offers her views on the state of play in the UK pension risk transfer market as we approach the halfway point of 2025.
Martin Kramer, Managing Partner at Ceptar Consulting, shares what’s been happening in the tertiary part of the life settlement world for this month’s Q&A.
W L Consulting’s Roger Lawrence offers his views on the UK’s Life Insurance Stress Test.
Mark Sharkey, BPA Origination Lead, Royal London shares his views on the state of the market and its outlook for 2025.
Life Risk News Q&A: Ryan McTernan, Senior Managing Director at Fifth Season Investments shares his take on the state of the life settlement market as we begin 2025.
Life Risk News Q&A: Cobus Daneel, Chair, Continuous Mortality Investigation Projections Committee, shares what is top of mind in the mortality actuarial world as we look ahead to 2025.